This finding will contribute to the understanding of cartilage diseases caused by genomic mutation and genome - based drug discovery for disease therapies. (sciencedaily.com)
Research from Rutgers Cancer Institute of New Jersey shows genomic profiling identifies genomic mutations in a gene associated with a rare subset of breast cancer — mutations that can not otherwise be identified with standard clinical analysis of cells and tissue. (sciencedaily.com)
New Brunswick, N.J. — Research from Rutgers Cancer Institute of New Jersey shows genomic profiling identifies genomic mutations in a gene associated with a rare subset of breast cancer — mutations that can not otherwise be identified with standard clinical analysis of cells and tissue. (cinj.org)